argenx SE ARGX 深 滬
等待開盤 07-31 09:30:00 美东时间
872.58
-9.980
-1.13%
華盛通- 最 高875.25
- 今 開861.00
- 成交量 25.67万股
- 最 低 855.87
- 昨 收 882.56
- 總市值 545.89亿
- 52周最高 953.58
- 市盈率 靜 44.46
- 換手率 0.41%
- 52周最低 631.47
- 委 比 90.34%
- 總股本 6256.10万
- 歷史最高 953.58
- 量 比 0.75
- 振 幅 2.20%
- 歷史最低 19.00
- 每 手 1
- 風險率 74.88%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅129.15%！HC Wainwright & Co.升Q32 Bio(QTTB)目标价至36美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Q32 Bio"买入"评级，目标价从13美元升至36美元；Chardan Capital：维持ProMIS Neurosciences"买入"评级，目标价从20美元升至33美元
07-29 11:37
美股大行评级 | ITG、Bending Spoons获多家大行首予买入评级；瑞银下调微软目标价从510美元降至480美元
今日重点评级关注：BTIG：上调Outlook Therapeutics"买入"评级，目标价4美元；TD Cowen：维持Nakamoto"买入"评级，目标价从1美元升至17美元
07-28 11:34
Argenx Secures Promising Autoimmune Drug In Forte Biosciences Takeover
Global immunology pioneer Argenx SE (NASDAQ:ARGX) on Monday struck a definitive agreement to purchase Forte Biosciences, Inc. (NASDAQ:FBRX) in a substantial all-cash transaction. Priced at $77 per share, the buyout commands a total equity value of roughly $2.2 billion, signaling a major strategic ex...
07-28 00:16
Why Forte Biosciences Shares Are Trading Higher By 39%; Here Are 20 Stocks Moving Premarket
Shares of Forte Biosciences Inc (NASDAQ:FBRX) rose sharply in pre-market trading after argenx SE – ADR (NASDAQ:ARGX) announced plans to acquire the company for $77 per share in cash, valuing the deal at $2.2 billion. Forte Biosciences shares jumped 38.9% to $76.10 in pre-market trading. Here are som...
07-27 17:09
argenx strikes $2.2B deal for Forte Biosciences
argenx SE (ARGX) to acquire Forte Biosciences (FBRX) for $77 per share in cash, valuing the transaction at ~$2.2B. The acquisition will add Forte’s lead program, FB102, a first-in-class anti-CD122 ant...
07-27 16:20
美股大行评级 | 最高120美元！大小摩等7家大行集体上调英特尔目标价；汇丰首予SpaceX"持有"评级，目标价115美元
今日重点评级关注：HC Wainwright & Co.：维持居里"买入"评级，目标价从17美元升至43美元；花旗：维持Klaviyo"买入"评级，目标价从31美元升至34美元
07-27 14:02
argenx SE shares are trading higher after the company reported better-than-expected Q2 financial results.
argenx SE shares are trading higher after the company reported better-than-expected Q2 financial results.
07-23 19:49
Earnings Scheduled For July 23, 2026
Companies Reporting Before The Bell • Altisource Portfolio (NASDAQ:ASPS) is estimated to report quarterly earnings at $0.18 per share on revenue of $42.90 million. • Dime Commercial (NYSE:DCOM) is expected to report quarterly earnings at $0.78 per share on revenue of $123.06 million. • Infosys (NYSE...
07-23 19:11
argenx Q2 EPS $7.32 Beats $6.24 Estimate, Sales $1.542B Beat $1.442B Estimate
argenx (NASDAQ:ARGX) reported quarterly earnings of $7.32 per share which beat the analyst consensus estimate of $6.24 by 17.31 percent. This is a 95.72 percent increase over earnings of $3.74 per share from the same period last year. The company reported quarterly sales of $1.542 billion which beat...
07-23 13:18
美股大行评级 | 富国银行上调亚马逊目标价从313美元升至322美元；潜在涨幅370.99%！HC Wainwright上调Greenwich LifeSciences目标价至69美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Greenwich LifeSciences"买入"评级，目标价从50美元升至69美元；高盛：维持Taysha Gene Therapies"买入"评级，目标价从11美元升至13美元
07-22 11:35
